The Effect of Prasugrel as Compared to Clopidogrel on Platelet Function Immediately Following the Termination of Intravenous Bivalirudin in Patients Undergoing Percutaneous Coronary and Structural Cardiac Intervention
Phase of Trial: Phase IV
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Stent thrombosis
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 22 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Apr 2014 Planned number of patients changed from 24 to 30 as reported by ClinicalTrials.gov.